Techulon is a Blacksburg, Virginia-based company with over $3.5M in investments from private and public sources. The company is an early-stage translational firm that maintains a strong collaborative relationship with Virginia Tech and was founded by leadership within the University’s College of Science. The company’s management team is seasoned in biotech startups, applied R&D, and commercialization. Techulon’s unique ability to pioneer effective delivery mechanisms for therapeutic applications formed the basis for the first products. The company maintains offices with a full research lab at the Virginia Tech Corporate Research Center.